Medical Device Spain içindeki etkinlikler

INFARMA

INFARMA: Europe’s Premier Pharmaceutical Trade Fair

INFARMA is a leading pharmaceutical trade fair in Europe, held annually and alternating between Madrid and Barcelona. The name “INFARMA” stands for International Pharmacy Meeting and Medicines Exhibition, highlighting the event’s global relevance in the pharmaceutical sector. The fair is organized by the Col·legi de Farmacèutics de Barcelona, in collaboration with the Colegio Oficial de Farmacéuticos de Madrid (COFM) and CloserStill Media, bringing together decades of expertise in healthcare exhibition management.

INFARMA serves as a central hub for professional exchange, innovation, and discussion within the pharmaceutical industry. It enables participants to stay informed about the latest trends, regulatory updates, and technological advancements shaping the sector.

Focus Areas and Key Themes

The exhibition covers a wide spectrum of topics that reflect the current priorities and future direction of the pharmaceutical industry, including:

Pharmaceutical innovations – new medicines, advanced therapies, biologics, and precision medicine solutions.

Digital transformation in healthcare – pharmacy management software, telepharmacy platforms, and AI-powered solutions for patient care.

Regulatory developments – updates on European and global pharmaceutical regulations, quality standards, and compliance requirements.

Clinical pharmacy and public health – best practices in clinical pharmacy, vaccination programs, disease prevention, and patient safety.

Sustainability in the pharmaceutical sector – environmentally responsible production, green logistics, and circular economy initiatives.

Through this broad thematic coverage, INFARMA ensures that pharmacists and healthcare professionals gain insight into both operational and strategic aspects of modern pharmacy practice.

Exhibitors and Innovations

INFARMA attracts a diverse range of exhibitors, from multinational pharmaceutical companies and biotech innovators to technology providers, service organizations, and startups. Highlights include:

New medicines and advanced therapies – including personalized and specialty drugs.

Digital pharmacy solutions – electronic prescriptions, pharmacy automation, patient management tools.

Healthcare services and consultancy – clinical support services, pharmacy optimization, and workflow efficiency solutions.

Medical devices and diagnostic tools – products that complement pharmaceutical care and enhance patient outcomes.

This comprehensive offering enables attendees to discover cutting-edge solutions and integrate them into everyday pharmacy practice.

Conferences, Workshops, and Professional Development

INFARMA’s value extends beyond the exhibition floor. The event features a rich program of conferences, lectures, and workshops, designed to:

Address current industry challenges, from regulatory changes to market dynamics.

Explore best practices in pharmacy management, patient care, and clinical services.

Showcase innovative digital tools and healthcare solutions to improve operational efficiency.

Facilitate knowledge sharing and networking among pharmacists, healthcare providers, and decision-makers.

The combination of educational sessions and practical demonstrations ensures participants leave with actionable insights and a clear understanding of emerging trends in the pharmaceutical sector.

Target Audience

INFARMA draws a specialized and highly engaged audience, including:

Community and hospital pharmacists seeking innovation and professional development.

Pharmaceutical experts and industry leaders interested in networking and collaboration.

Healthcare providers and policy-makers focused on patient care, clinical pharmacy, and public health.

Technology and service providers looking to engage with decision-makers in the pharmacy sector.

This diverse attendance ensures rich professional interactions, business opportunities, and strategic partnerships.

Strategic Importance

INFARMA is not only an exhibition it is a strategic platform for the advancement of pharmacy practice and healthcare innovation in Europe. By combining innovative product showcases, expert-led conferences, and networking opportunities, the fair strengthens the pharmaceutical ecosystem.

Pharmacists gain access to state-of-the-art solutions, insights on regulatory updates, and opportunities to enhance patient care. For companies, INFARMA provides a high-impact platform to present products, services, and technologies to an engaged and influential audience.

In summary, INFARMA stands as Europe’s premier pharmaceutical trade fair, offering a comprehensive view of the industry through its exhibition, conferences, and networking events. By connecting pharmacists, healthcare professionals, innovators, and decision-makers, the fair promotes knowledge exchange, innovation adoption, and collaboration that are essential for the growth and modernization of the pharmaceutical sector.

For anyone involved in pharmacy, healthcare, or pharmaceutical innovation, INFARMA is a must-attend event that combines education, networking, and business opportunities on an international scale.

NanoMed Europe

NanoMed Europe: Celebrating Innovation and Milestones in Nanomedicine

NanoMed Europe, the flagship European conference dedicated to nanomedicine, returns with an extraordinary edition that goes beyond the ordinary. This year’s event marks a double anniversary: the celebration of both ETPN (European Technology Platform on Nanomedicine) and NanoMed Spain, two cornerstones in the development and promotion of nanomedicine across Europe.

Hosted in Spain, this edition of NanoMed Europe is not only a scientific gathering—it is a tribute to two decades of collaborative progress, groundbreaking discoveries, and visionary strategies that have shaped the field of nanomedicine in Europe. Researchers, clinicians, policymakers, and innovators will come together to honor achievements, reflect on challenges, and chart a bold new path for the future.
Nanomedicine: The Fusion of Science and Healing at the Nanoscale

Nanomedicine, a field where nanotechnology meets life sciences, continues to redefine diagnostics, targeted therapies, drug delivery, and regenerative medicine. It represents one of the most promising frontiers in healthcare, enabling treatment precision and personalization that were unthinkable a generation ago.

Key areas of nanomedicine explored at the conference include:

Nanodiagnostics and real-time imaging

Targeted drug delivery systems for cancer and chronic diseases

Nanotherapeutics and smart nanocarriers

Nanobiosensors for point-of-care diagnostics

Nanomaterials in tissue engineering and regenerative medicine

Clinical translation of nano-enabled technologies

These focus areas highlight the vast scope of NanoMed Europe and its role in promoting cross-sector innovation, bridging academic research with industrial application and clinical adoption.

Why This Edition Is Unmissable: Two Milestones, One Vision

This year’s NanoMed Europe is a landmark occasion, marking the anniversaries of:

ETPN (European Technology Platform on Nanomedicine): A European Commission initiative launched to coordinate and accelerate the development of nanomedicine in Europe. ETPN has been instrumental in shaping policy, funding, and strategic direction in the field.

NanoMed Spain: The national nanomedicine platform of Spain, which has played a crucial role in building a strong scientific and industrial ecosystem, supporting translational research, and fostering international collaborations.

This anniversary edition offers:

Commemorative sessions on the history and impact of ETPN and NanoMed Spain.

Special keynote lectures from pioneers in nanomedicine and healthcare innovation.

Panel discussions reflecting on achievements and future priorities.

Networking receptions and celebratory events highlighting community spirit.

Showcase of collaborative European projects and funding opportunities.

This dual celebration enhances the sense of purpose and community, making NanoMed Europe 2025 an unforgettable experience for all attendees.

Who Should Attend NanoMed Europe?

NanoMed Europe gathers a vibrant, multidisciplinary audience that reflects the ecosystem required to bring nanomedicine from lab to bedside. From early-stage researchers to pharmaceutical executives, the conference is designed to engage all actors of the innovation chain.
Attendee profiles include:

Biomedical and materials scientists

Clinical researchers and physicians

Nanotechnology engineers

Pharmaceutical and biotech companies

Regulatory and funding authorities

Startups and venture capitalists

National and European project coordinators

IP and technology transfer specialists

The wide spectrum of participants ensures that science, industry, regulation, and investment converge to create meaningful and implementable outcomes.

A Conference Designed for Impact and Interaction

While NanoMed Europe is anchored in science, it is equally focused on creating actionable pathways to market. The program is rich in content, offering opportunities for learning, networking, and deal-making.

Highlights of the conference program:

Scientific sessions with high-impact research presentations

Workshops on translational pathways and clinical trials

Business and innovation forums connecting startups with investors

Poster sessions showcasing emerging research from young scientists

Interactive Q&A and roundtables for cross-disciplinary dialogue

Project matchmaking opportunities for EU-funded initiatives

With its balance of academic rigor and practical application, the event remains a powerful accelerator of real-world progress in nanomedicine.

Supporting the Next Generation of Innovators

A core mission of NanoMed Europe is to empower early-career professionals. Young researchers and entrepreneurs are given a prominent platform to present, connect, and grow.

Special initiatives for young professionals include:

Best Poster and Presentation Awards

Career development sessions

Start-up pitch competitions

One-on-one mentoring from senior leaders

Travel grants and bursaries for eligible participants

By investing in the next generation, NanoMed Europe ensures continuity, sustainability, and the emergence of future leaders in the field.

Building a Stronger European Nanomedicine Ecosystem

Over the years, both ETPN and NanoMed Spain have been at the forefront of strengthening Europe’s position in global nanomedicine. This year’s conference serves as a reaffirmation of their shared vision: building an integrated ecosystem where innovation is supported from bench to market.

Strategic priorities discussed at the event will include:

Scaling clinical translation of nano-based therapies

Enhancing cross-border collaboration through EU funding

Strengthening regulatory frameworks and harmonization

Promoting public-private partnerships

Supporting SMEs and startups in deep-tech and nanotech fields

These themes position NanoMed Europe not just as a scientific gathering, but as a strategic engine for Europe's healthcare future.

A Celebration of Progress, and a Vision for Tomorrow

This special edition of NanoMed Europe is more than a conference—it is a celebration of vision, commitment, and collaborative success. As ETPN and NanoMed Spain mark major anniversaries, the event offers a rare opportunity to honor the past while boldly embracing the future.

In a world where precision medicine and advanced therapeutics are becoming the new standard, nanomedicine holds the promise of revolutionizing care at the cellular and molecular levels. NanoMed Europe 2025 stands at the heart of this transformation—uniting knowledge, experience, and ambition across disciplines and borders.

Whether you're an innovator, clinician, policymaker, or entrepreneur, NanoMed Europe is where the future of medicine begins—at the nanoscale.